Interleukin-12 Antagonist [EPC]

Interleukin-12 Antagonist [EPC] was reported 103830 times

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 414 0.6198
1 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
2 RHEUMATIC FEVER 2543 0.5699
3 LUPUS VULGARIS 682 0.5413
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
5 C-REACTIVE PROTEIN 492 0.5307
6 RHEUMATOID FACTOR POSITIVE 2982 0.5157
7 SWOLLEN JOINT COUNT 128 0.5120
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
9 GRIP STRENGTH 113 0.4934
10 RED BLOOD CELL SEDIMENTATION RATE 127 0.4552
11 FACET JOINT SYNDROME 1431 0.4391
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4257
13 DUODENAL ULCER PERFORATION 3156 0.4240
14 X-RAY ABNORMAL 735 0.4106
15 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 216 0.3850
16 RETINITIS 661 0.3823
17 DISLOCATION OF VERTEBRA 838 0.3671
18 ILEOCAECAL RESECTION 123 0.3576
19 NEUROLOGIC NEGLECT SYNDROME 178 0.3201
20 HELICOBACTER INFECTION 3256 0.3165
21 PEMPHIGUS 3944 0.3151
22 HAND DEFORMITY 4061 0.3093
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 32 0.3048
24 C-REACTIVE PROTEIN ABNORMAL 1788 0.2785
25 MUSCLE INJURY 2219 0.2675
26 PERIPHERAL VENOUS DISEASE 1080 0.2642
27 SERONEGATIVE ARTHRITIS 298 0.2600
28 SYNOVITIS 4640 0.2571
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1654 0.2544
30 FOLLICULITIS 2611 0.2487
31 PERICARDITIS 3881 0.2308
32 CONTRAINDICATION TO VACCINATION 42 0.2199
33 BONE EROSION 777 0.2195
34 ILEECTOMY 72 0.2136
35 CAROTID ARTERY THROMBOSIS 181 0.2132
36 HYPOCHOLESTEROLAEMIA 65 0.1841
37 GLOSSODYNIA 4074 0.1818
38 PROCTOCOLECTOMY 55 0.1803
39 GRANULOMA SKIN 143 0.1742
40 ENTHESOPATHY 272 0.1738
41 DRUG TOLERANCE DECREASED 472 0.1679
42 PORPHYRIA ACUTE 236 0.1645
43 BREAST CANCER STAGE III 1042 0.1607
44 LIP DRY 1461 0.1607
45 OVERLAP SYNDROME 106 0.1514
46 WOUND 4231 0.1512
47 HYPERCHOLESTEROLAEMIA 1353 0.1400
48 JOINT RANGE OF MOTION DECREASED 1828 0.1362
49 ADJUSTMENT DISORDER 176 0.1354
50 TERMINAL ILEITIS 83 0.1352
51 WOUND INFECTION 1478 0.1348
52 GRIP STRENGTH DECREASED 1176 0.1335
53 SYRINGE ISSUE 2297 0.1311
54 INTESTINAL ANASTOMOSIS 84 0.1304
55 ONYCHOMADESIS 525 0.1250
56 FAECAL CALPROTECTIN ABNORMAL 51 0.1229
57 PUSTULAR PSORIASIS 421 0.1225
58 ANASTOMOTIC STENOSIS 45 0.1210
59 SYSTEMIC LUPUS ERYTHEMATOSUS 4292 0.1208
60 IRRITABLE BOWEL SYNDROME 2550 0.1188
61 DEATH NEONATAL 155 0.1114
62 BURSITIS 1347 0.1109
63 AUTOIMMUNE DISORDER 1079 0.1106
64 LIVE BIRTH 922 0.1101
65 PSORIATIC ARTHROPATHY 4422 0.1088
66 BLOOD PARATHYROID HORMONE DECREASED 158 0.1065
67 ERYTHRODERMIC PSORIASIS 85 0.1032
68 ARTHRITIS ENTEROPATHIC 33 0.1012
69 FIBROMYALGIA 2434 0.1000
70 BLEPHAROSPASM 615 0.0976
71 TENOSYNOVITIS 267 0.0967
72 CONTRAINDICATED PRODUCT ADMINISTERED 2912 0.0961
73 INTESTINAL RESECTION 513 0.0953
74 LOWER RESPIRATORY TRACT INFECTION 4259 0.0936
75 JOINT ANKYLOSIS 53 0.0933
76 ONYCHOMYCOSIS 403 0.0918
77 ILEAL STENOSIS 160 0.0899
78 SMALL INTESTINAL RESECTION 104 0.0892
79 EXOSTOSIS 804 0.0880
80 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
81 LUPUS-LIKE SYNDROME 783 0.0863
82 TYPE 2 DIABETES MELLITUS 2906 0.0862
83 INFECTED FISTULA 46 0.0858
84 LIVER INJURY 2101 0.0855
85 ILEOSTOMY 210 0.0822
86 IMPAIRED HEALING 2667 0.0812
87 DEVICE DEFECTIVE 1399 0.0806
88 LATENT TUBERCULOSIS 168 0.0802
89 THERAPEUTIC PRODUCT EFFECT DECREASED 3552 0.0792
90 SCIATICA 1263 0.0791
91 INFUSION RELATED REACTION 5236 0.0789
92 FINGER DEFORMITY 373 0.0769
93 RED BLOOD CELL SEDIMENTATION RATE INCREASED 847 0.0765
94 POSTOPERATIVE ABSCESS 51 0.0761
95 OBESITY 1178 0.0739
96 NEEDLE ISSUE 2138 0.0734
97 ARTHROPATHY 4078 0.0733
98 ANAL ABSCESS 395 0.0732
99 ANAL STENOSIS 39 0.0732
100 FAECAL CALPROTECTIN INCREASED 230 0.0726
101 HIP ARTHROPLASTY 1088 0.0710
102 NAIL DISORDER 619 0.0707
103 PANNICULITIS 171 0.0706
104 WALKING AID USER 461 0.0698
105 RECTAL ABSCESS 116 0.0691
106 JOINT DISLOCATION 727 0.0687
107 PRODUCT LEAKAGE 385 0.0685
108 PERSONALITY DISORDER 178 0.0679
109 HEPATIC ENZYME INCREASED 4532 0.0664
110 COLECTOMY TOTAL 37 0.0663
111 ILEAL ULCER 66 0.0652
112 GUTTATE PSORIASIS 53 0.0646
113 FOOT DEFORMITY 709 0.0639
114 PULMONARY FIBROSIS 1212 0.0631
115 MATERNAL EXPOSURE TIMING UNSPECIFIED 237 0.0630
116 SPONDYLITIS 229 0.0629
117 LOWER LIMB FRACTURE 1189 0.0618
118 COLECTOMY 347 0.0614
119 RHEUMATOID NODULE 165 0.0598
120 LARGE INTESTINAL STENOSIS 119 0.0595
121 DEVICE DEPLOYMENT ISSUE 751 0.0587
122 PRESCRIBED OVERDOSE 1108 0.0572
123 BLOOD CHOLESTEROL INCREASED 2655 0.0569
124 DISCOMFORT 3460 0.0567
125 INTESTINAL STENOSIS 239 0.0566
126 CUTANEOUS T-CELL LYMPHOMA 70 0.0556
127 ABSCESS INTESTINAL 119 0.0552
128 DRUG SPECIFIC ANTIBODY 75 0.0547
129 SACROILIITIS 103 0.0545
130 PRODUCT LABEL CONFUSION 317 0.0543
131 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 127 0.0535
132 BLISTER 2919 0.0519
133 BREAST CANCER STAGE II 426 0.0512
134 INTESTINAL OPERATION 81 0.0511
135 PYODERMA GANGRENOSUM 183 0.0508
136 PSORIASIS 6636 0.0508
137 KNEE ARTHROPLASTY 1063 0.0504
138 ANAL FISTULA 269 0.0504
139 HEPATIC CIRRHOSIS 942 0.0501
140 RASH VESICULAR 242 0.0500
141 DACTYLITIS 49 0.0499
142 GAIT INABILITY 1660 0.0496
143 GROIN ABSCESS 58 0.0492
144 INFUSION SITE REACTION 147 0.0492
145 STOMA CREATION 34 0.0490
146 ENTEROCUTANEOUS FISTULA 43 0.0488
147 EYE INJURY 148 0.0487
148 TREATMENT FAILURE 3938 0.0475
149 STENOSIS 89 0.0473
150 SUSPECTED OFF LABEL USE 214 0.0473
151 SMALL INTESTINAL STENOSIS 50 0.0469
152 INTESTINAL FISTULA 66 0.0468
153 BACK INJURY 507 0.0466
154 OSTEOARTHRITIS 1967 0.0463
155 RHEUMATOID LUNG 44 0.0461
156 ULCER HAEMORRHAGE 312 0.0461
157 DRUG INTOLERANCE 4327 0.0447
158 PERFORATION 36 0.0447
159 STOMATITIS 2693 0.0444
160 NIGHT SWEATS 1408 0.0437
161 SWELLING 4070 0.0434
162 RHEUMATOID ARTHRITIS 4920 0.0433
163 CHOLANGITIS SCLEROSING 89 0.0433
164 C-REACTIVE PROTEIN INCREASED 1576 0.0433
165 PRODUCT OUTER PACKAGING ISSUE 39 0.0431
166 LOSS OF THERAPEUTIC RESPONSE 135 0.0423
167 PRESCRIBED UNDERDOSE 833 0.0417
168 LIVER FUNCTION TEST INCREASED 889 0.0414
169 INFLAMMATION 2107 0.0408
170 GASTROENTERITIS NOROVIRUS 54 0.0406
171 MOBILITY DECREASED 2917 0.0406
172 JOINT SWELLING 4797 0.0397
173 POUCHITIS 34 0.0395
174 TUBERCULIN TEST POSITIVE 100 0.0395
175 BONE CYST 37 0.0394
176 INJURY 2753 0.0391
177 ABDOMINAL ABSCESS 172 0.0389
178 GASTROINTESTINAL WALL THICKENING 58 0.0387
179 DRUG DELIVERY SYSTEM MALFUNCTION 198 0.0387
180 FISTULA 429 0.0381
181 FISTULA DISCHARGE 48 0.0380
182 COELIAC DISEASE 370 0.0377
183 CONGENITAL ANOMALY 290 0.0374
184 MUSCULOSKELETAL STIFFNESS 3254 0.0371
185 EXPOSURE DURING PREGNANCY 2302 0.0370
186 BASAL CELL CARCINOMA 574 0.0368
187 DRUG LEVEL DECREASED 372 0.0365
188 INJECTION RELATED REACTION 60 0.0363
189 WHEEZING 2139 0.0360
190 THERAPY NON-RESPONDER 1583 0.0352
191 GENERAL PHYSICAL HEALTH DETERIORATION 4047 0.0349
192 PRODUCT DOSE OMISSION ISSUE 10264 0.0349
193 SPINAL FUSION SURGERY 141 0.0347
194 MALIGNANT MELANOMA IN SITU 43 0.0347
195 COLOSTOMY 68 0.0346
196 COLITIS ULCERATIVE 1545 0.0345
197 ROAD TRAFFIC ACCIDENT 1441 0.0344
198 PROSTATE INFECTION 33 0.0343
199 INFECTED CYST 41 0.0342
200 ADENOCARCINOMA OF COLON 64 0.0341
201 ILL-DEFINED DISORDER 2060 0.0339
202 LIQUID PRODUCT PHYSICAL ISSUE 247 0.0338
203 DERMATITIS PSORIASIFORM 69 0.0337
204 GASTROINTESTINAL STOMA COMPLICATION 53 0.0337
205 ABSCESS 536 0.0336
206 MATERNAL EXPOSURE DURING PREGNANCY 2984 0.0334
207 INTESTINAL ULCER 52 0.0327
208 PERTUSSIS 34 0.0326
209 SKIN NECROSIS 169 0.0325
210 LIVER DISORDER 1421 0.0320
211 TONGUE DISORDER 230 0.0318
212 SQUAMOUS CELL CARCINOMA 299 0.0317
213 GANGRENE 191 0.0317
214 JOINT STIFFNESS 831 0.0316
215 OEDEMA 1711 0.0315
216 FREQUENT BOWEL MOVEMENTS 842 0.0311
217 VEIN RUPTURE 52 0.0310
218 DRUG TOLERANCE 156 0.0308
219 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 71 0.0308
220 GASTROINTESTINAL BACTERIAL INFECTION 35 0.0306
221 DRUG LEVEL BELOW THERAPEUTIC 168 0.0304
222 LUNG DISORDER 1451 0.0296
223 SLEEP DISORDER 2071 0.0293
224 PRODUCT USE ISSUE 5476 0.0291
225 EAR INFECTION 772 0.0290
226 SINUSITIS 2948 0.0287
227 GENERAL SYMPTOM 215 0.0287
228 GASTROINTESTINAL DISORDER 2531 0.0282
229 POSTOPERATIVE WOUND INFECTION 190 0.0281
230 CERVICAL DYSPLASIA 61 0.0279
231 INTESTINAL DILATATION 37 0.0277
232 PRODUCT LABEL ISSUE 187 0.0275
233 DRUG-INDUCED LIVER INJURY 861 0.0274
234 SENSORY LOSS 220 0.0273
235 JOINT DESTRUCTION 42 0.0270
236 FEMALE GENITAL TRACT FISTULA 46 0.0269
237 INTENTIONAL PRODUCT USE ISSUE 2359 0.0269
238 INFLAMMATORY BOWEL DISEASE 263 0.0269
239 MYOSITIS 239 0.0266
240 MUCOUS STOOLS 131 0.0264
241 TOOTH ABSCESS 269 0.0264
242 DELIRIUM 909 0.0262
243 ABDOMINAL DISCOMFORT 4391 0.0262
244 NORMAL NEWBORN 142 0.0261
245 TASTE DISORDER 529 0.0260
246 ADVERSE REACTION 344 0.0259
247 MUSCULOSKELETAL PAIN 1354 0.0258
248 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 443 0.0258
249 GASTROINTESTINAL INFLAMMATION 202 0.0258
250 PREGNANCY 515 0.0257
251 SUBCUTANEOUS ABSCESS 123 0.0256
252 PRODUCT DOSE OMISSION 1671 0.0256
253 HYPERSENSITIVITY 4739 0.0255
254 DISABILITY 504 0.0255
255 TONSILLITIS 133 0.0255
256 DRUG ERUPTION 450 0.0254
257 DERMATITIS EXFOLIATIVE GENERALISED 87 0.0250
258 INFECTION 3602 0.0249
259 SKIN PLAQUE 207 0.0245
260 PRODUCT PACKAGING ISSUE 233 0.0245
261 LARGE INTESTINAL ULCER 66 0.0243
262 PROCTITIS 68 0.0243
263 THERAPEUTIC RESPONSE DECREASED 1471 0.0242
264 CLOSTRIDIUM DIFFICILE INFECTION 521 0.0238
265 EPILEPSY 720 0.0235
266 ALOPECIA 4615 0.0235
267 MUSCLE SPASTICITY 287 0.0233
268 HEMIPLEGIA 194 0.0233
269 ARTERIAL OCCLUSIVE DISEASE 183 0.0233
270 INCORRECT PRODUCT STORAGE 304 0.0231
271 SINUS CONGESTION 310 0.0229
272 DEVICE ISSUE 2021 0.0225
273 DRUG SPECIFIC ANTIBODY PRESENT 146 0.0224
274 PAPILLOMA VIRAL INFECTION 37 0.0224
275 CHOLANGIOCARCINOMA 33 0.0221
276 SALMONELLOSIS 37 0.0219
277 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1558 0.0219
278 HEPATIC FIBROSIS 75 0.0218
279 ARTHRITIS 1715 0.0218
280 GASTROINTESTINAL INFECTION 195 0.0217
281 POST PROCEDURAL INFECTION 176 0.0216
282 IGA NEPHROPATHY 35 0.0211
283 ENTERITIS 135 0.0211
284 SKIN HAEMORRHAGE 310 0.0209
285 CONTUSION 1999 0.0207
286 INVASIVE DUCTAL BREAST CARCINOMA 56 0.0206
287 GRANULOMA 71 0.0205
288 ERYSIPELAS 102 0.0203
289 DRY MOUTH 1646 0.0203
290 NASOPHARYNGITIS 3732 0.0202
291 OSTEOPOROSIS 827 0.0201
292 KIDNEY INFECTION 393 0.0200
293 AFFECT LABILITY 190 0.0197
294 SMALL INTESTINAL OBSTRUCTION 242 0.0196
295 PRODUCT CONTAINER SEAL ISSUE 34 0.0195
296 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 928 0.0193
297 ANORECTAL DISORDER 38 0.0190
298 TENDONITIS 295 0.0190
299 VITAMIN B12 DEFICIENCY 77 0.0190
300 PERIPHERAL SWELLING 2888 0.0187
301 SUBILEUS 39 0.0187
302 CYTOMEGALOVIRUS COLITIS 43 0.0187
303 URTICARIA 3127 0.0186
304 MOTOR DYSFUNCTION 190 0.0186
305 ADVERSE EVENT 1717 0.0186
306 ABSCESS LIMB 79 0.0185
307 MALIGNANT MELANOMA 248 0.0185
308 DEFAECATION URGENCY 129 0.0184
309 ABDOMINAL INFECTION 47 0.0184
310 WEIGHT FLUCTUATION 192 0.0183
311 VARICELLA ZOSTER VIRUS INFECTION 38 0.0183
312 HYPOAESTHESIA 2712 0.0181
313 HIDRADENITIS 164 0.0180
314 JOINT ARTHROPLASTY 32 0.0179
315 SELF-MEDICATION 73 0.0177
316 CELLULITIS 887 0.0176
317 CONDITION AGGRAVATED 5350 0.0176
318 ANTINUCLEAR ANTIBODY POSITIVE 57 0.0175
319 ULCER 279 0.0175
320 SKIN INJURY 58 0.0175
321 POLYARTHRITIS 92 0.0174
322 ADVERSE DRUG REACTION 1562 0.0174
323 FEAR OF INJECTION 124 0.0174
324 UPPER RESPIRATORY TRACT INFECTION 800 0.0173
325 MIGRAINE 1645 0.0172
326 OSTEOLYSIS 35 0.0171
327 SKIN INFECTION 192 0.0171
328 RHEUMATIC DISORDER 33 0.0171
329 GASTROINTESTINAL OBSTRUCTION 41 0.0170
330 OBSTRUCTION 68 0.0170
331 DYSPEPSIA 1669 0.0169
332 INTESTINAL OBSTRUCTION 635 0.0168
333 CONFUSIONAL STATE 2718 0.0168
334 RENAL NEOPLASM 35 0.0165
335 DYSCHEZIA 50 0.0164
336 EAR PAIN 318 0.0163
337 HEPATITIS 417 0.0163
338 ERYTHEMA NODOSUM 57 0.0162
339 ANAL FISSURE 87 0.0162
340 HYPERTENSION 3417 0.0161
341 DIARRHOEA HAEMORRHAGIC 150 0.0160
342 GASTRIC INFECTION 61 0.0159
343 HEPATIC STEATOSIS 297 0.0159
344 PRODUCT STORAGE ERROR 1387 0.0158
345 EXPOSURE VIA BREAST MILK 63 0.0158
346 DEMYELINATION 64 0.0156
347 UNDERDOSE 1129 0.0155
348 SUSPECTED COVID-19 51 0.0154
349 VITILIGO 36 0.0153
350 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2751 0.0152
351 BACK DISORDER 247 0.0152
352 VARICELLA 36 0.0151
353 LYME DISEASE 50 0.0150
354 SKIN PAPILLOMA 60 0.0149
355 INFLAMMATORY MARKER INCREASED 74 0.0149
356 OFF LABEL USE 12939 0.0148
357 ADENOCARCINOMA 33 0.0147
358 RECTAL CANCER 45 0.0146
359 ACCIDENTAL EXPOSURE TO PRODUCT 1505 0.0146
360 AMNESIA 949 0.0146
361 FACIAL PARALYSIS 124 0.0145
362 ARTHRALGIA 5921 0.0142
363 WEIGHT INCREASED 3180 0.0142
364 HAEMATOCHEZIA 780 0.0141
365 APPENDICITIS 132 0.0141
366 RESPIRATORY DISORDER 422 0.0141
367 RESPIRATORY TRACT CONGESTION 223 0.0140
368 DENGUE FEVER 32 0.0139
369 PUSTULE 33 0.0139
370 SINUS DISORDER 273 0.0138
371 LUNG ADENOCARCINOMA 41 0.0136
372 PNEUMONIA 4400 0.0136
373 COORDINATION ABNORMAL 189 0.0135
374 RESPIRATORY TRACT INFECTION 352 0.0135
375 HYPERCALCAEMIA 166 0.0134
376 CUSHINGOID 43 0.0134
377 GUILLAIN-BARRE SYNDROME 64 0.0132
378 RASH 5725 0.0131
379 SURGERY 762 0.0130
380 CHOLECYSTITIS INFECTIVE 36 0.0130
381 DERMATITIS EXFOLIATIVE 64 0.0128
382 MUSCULAR WEAKNESS 1448 0.0127
383 RECTAL HAEMORRHAGE 544 0.0126
384 APPENDICECTOMY 45 0.0126
385 SKIN CANCER 266 0.0123
386 CYSTITIS 390 0.0122
387 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 208 0.0122
388 ASTHMA 1377 0.0122
389 APHTHOUS ULCER 94 0.0121
390 STREPTOCOCCAL INFECTION 67 0.0120
391 COLITIS 456 0.0120
392 DRUG DOSE OMISSION 1984 0.0120
393 VARICES OESOPHAGEAL 36 0.0119
394 PHARYNGITIS 147 0.0118
395 RASH PUSTULAR 86 0.0118
396 HYPERTRANSAMINASAEMIA 82 0.0118
397 CUTANEOUS VASCULITIS 43 0.0118
398 SQUAMOUS CELL CARCINOMA OF SKIN 71 0.0117
399 IRON DEFICIENCY ANAEMIA 108 0.0117
400 ABDOMINAL PAIN UPPER 2406 0.0117
401 PROCTALGIA 75 0.0117
402 PLANTAR FASCIITIS 39 0.0116
403 HEMIPARESIS 196 0.0116
404 LOCALISED INFECTION 279 0.0115
405 ABDOMINAL PAIN 2676 0.0115
406 INTESTINAL PERFORATION 129 0.0115
407 SKIN ULCER 294 0.0114
408 CHEMOTHERAPY 43 0.0114
409 DRUG INEFFECTIVE 14981 0.0114
410 NECK PAIN 633 0.0113
411 MEDICATION ERROR 626 0.0113
412 CLOSTRIDIAL INFECTION 38 0.0112
413 FUNCTIONAL GASTROINTESTINAL DISORDER 38 0.0110
414 THERAPY CHANGE 108 0.0110
415 MELANOCYTIC NAEVUS 48 0.0109
416 IRON DEFICIENCY 49 0.0109
417 DIVERTICULITIS 301 0.0109
418 EATING DISORDER 231 0.0108
419 WOUND COMPLICATION 37 0.0108
420 MEMORY IMPAIRMENT 1477 0.0107
421 HYSTERECTOMY 93 0.0107
422 SNEEZING 240 0.0107
423 UVEITIS 145 0.0107
424 ARTHRITIS INFECTIVE 49 0.0106
425 PYELONEPHRITIS 91 0.0105
426 FURUNCLE 83 0.0105
427 PAIN 6337 0.0103
428 B-CELL LYMPHOMA 35 0.0103
429 SECRETION DISCHARGE 129 0.0103
430 BRONCHITIS 760 0.0103
431 DECREASED APPETITE 2368 0.0102
432 HERPES VIRUS INFECTION 58 0.0101
433 BILE DUCT STONE 32 0.0101
434 GASTROOESOPHAGEAL REFLUX DISEASE 808 0.0100
435 HEPATIC CYST 34 0.0100
436 GASTROENTERITIS 146 0.0100
437 DRUG EFFECT DECREASED 538 0.0100
438 CHEST PAIN 1848 0.0100
439 DEVICE MALFUNCTION 698 0.0099
440 SKIN DISORDER 330 0.0099
441 MUSCLE SPASMS 1815 0.0099
442 HEPATIC FUNCTION ABNORMAL 367 0.0098
443 OESOPHAGEAL CANDIDIASIS 39 0.0098
444 SARS-COV-2 TEST POSITIVE 129 0.0098
445 ANKYLOSING SPONDYLITIS 128 0.0097
446 LYMPHOMA 150 0.0097
447 RED CELL DISTRIBUTION WIDTH INCREASED 40 0.0096
448 PARAESTHESIA 1511 0.0096
449 PRODUCT USE IN UNAPPROVED INDICATION 2371 0.0096
450 TOOTH INFECTION 126 0.0095
451 INJECTION SITE REACTION 657 0.0095
452 SYMPTOM RECURRENCE 57 0.0095
453 PAIN IN EXTREMITY 2801 0.0095
454 ARTHRITIS BACTERIAL 39 0.0095
455 ARTHROPOD BITE 70 0.0094
456 STAPHYLOCOCCAL INFECTION 310 0.0094
457 CARPAL TUNNEL SYNDROME 131 0.0093
458 PRURITUS 3593 0.0093
459 OEDEMA PERIPHERAL 1139 0.0093
460 PRODUCT TEMPERATURE EXCURSION ISSUE 48 0.0093
461 PHARYNGITIS STREPTOCOCCAL 101 0.0093
462 NONSPECIFIC REACTION 51 0.0093
463 PYREXIA 3202 0.0092
464 ESCHERICHIA INFECTION 76 0.0092
465 NEPHROLITHIASIS 423 0.0092
466 PANCREATITIS 487 0.0092
467 LIVER FUNCTION TEST ABNORMAL 267 0.0092
468 VULVOVAGINAL MYCOTIC INFECTION 36 0.0091
469 HERPES ZOSTER 521 0.0091
470 VASCULAR DEVICE INFECTION 41 0.0090
471 SKIN LESION 247 0.0090
472 INFLUENZA 1004 0.0090
473 HAEMORRHAGIC DIATHESIS 32 0.0090
474 FATIGUE 6995 0.0090
475 HEPATOCELLULAR CARCINOMA 68 0.0089
476 FAECES SOFT 65 0.0089
477 WOUND SECRETION 35 0.0089
478 BOWEL MOVEMENT IRREGULARITY 68 0.0089
479 CHOLELITHIASIS 291 0.0089
480 ANGINA PECTORIS 254 0.0089
481 POLYP 58 0.0088
482 SARCOIDOSIS 42 0.0088
483 DRUG EFFECT INCOMPLETE 319 0.0088
484 RASH PRURITIC 475 0.0088
485 INTENTIONAL DOSE OMISSION 249 0.0087
486 OSTEOMYELITIS 158 0.0087
487 COLON CANCER 130 0.0087
488 INTRACRANIAL ANEURYSM 35 0.0087
489 MALAISE 3810 0.0087
490 PULMONARY TUBERCULOSIS 37 0.0087
491 IMMUNE SYSTEM DISORDER 114 0.0086
492 VIRAL UPPER RESPIRATORY TRACT INFECTION 41 0.0086
493 HEADACHE 5395 0.0086
494 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 610 0.0086
495 PREMATURE LABOUR 48 0.0085
496 SPINAL STENOSIS 35 0.0085
497 CERVIX CARCINOMA 33 0.0084
498 RHINITIS 68 0.0084
499 SHOULDER OPERATION 36 0.0084
500 GASTRIC DISORDER 287 0.0084
501 CHOLECYSTECTOMY 95 0.0083
502 STAPHYLOCOCCAL BACTERAEMIA 36 0.0083
503 INSOMNIA 2199 0.0082
504 EYE INFECTION 92 0.0081
505 THERAPY CESSATION 418 0.0081
506 HEPATITIS B 49 0.0081
507 HERNIA 156 0.0081
508 LUNG INFECTION 125 0.0080
509 INSURANCE ISSUE 123 0.0080
510 ABDOMINAL DISTENSION 839 0.0080
511 GAIT DISTURBANCE 1536 0.0080
512 DIVERTICULUM INTESTINAL 35 0.0080
513 ORAL CANDIDIASIS 105 0.0080
514 MALNUTRITION 89 0.0079
515 IMMUNOSUPPRESSION 70 0.0079
516 CONGESTIVE CARDIOMYOPATHY 33 0.0079
517 POOR QUALITY DRUG ADMINISTERED 51 0.0079
518 ANAL INCONTINENCE 70 0.0078
519 VISUAL IMPAIRMENT 962 0.0078
520 DEPRESSION 1764 0.0077
521 NEOPLASM 88 0.0076
522 LYMPHADENOPATHY 271 0.0076
523 ABDOMINAL TENDERNESS 38 0.0076
524 JOINT INJURY 163 0.0076
525 WHITE BLOOD CELL COUNT INCREASED 292 0.0076
526 BLOOD PRESSURE DIASTOLIC INCREASED 35 0.0076
527 IMMUNODEFICIENCY 113 0.0076
528 DEVICE PHYSICAL PROPERTY ISSUE 58 0.0076
529 LABORATORY TEST ABNORMAL 223 0.0075
530 DIARRHOEA 4840 0.0075
531 BLOOD PRESSURE SYSTOLIC INCREASED 146 0.0075
532 VITAMIN D DEFICIENCY 73 0.0075
533 ABDOMINAL HERNIA 34 0.0074
534 IMPAIRED QUALITY OF LIFE 107 0.0074
535 POOR QUALITY PRODUCT ADMINISTERED 78 0.0074
536 THYROID CANCER 89 0.0074
537 HERPES SIMPLEX 48 0.0074
538 DECREASED IMMUNE RESPONSIVENESS 72 0.0073
539 BLOOD IRON DECREASED 87 0.0073
540 VOMITING 3437 0.0073
541 APHASIA 220 0.0073
542 MENINGITIS 48 0.0072
543 BREAST MASS 48 0.0071
544 DEVICE RELATED INFECTION 110 0.0071
545 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 68 0.0071
546 PLEURISY 42 0.0071
547 FUNGAL INFECTION 235 0.0070
548 HOSPITALISATION 1081 0.0070
549 ORAL HERPES 137 0.0070
550 HEPATIC ENZYME ABNORMAL 35 0.0070
551 KNEE OPERATION 69 0.0070
552 CANDIDA INFECTION 118 0.0070
553 CATARACT 413 0.0069
554 GASTROENTERITIS VIRAL 125 0.0069
555 PULMONARY MASS 103 0.0069
556 PEMPHIGOID 52 0.0069
557 SKIN MASS 46 0.0069
558 CYST 85 0.0068
559 HIP SURGERY 37 0.0068
560 ABNORMAL FAECES 56 0.0068
561 WEIGHT DECREASED 1902 0.0068
562 MASS 95 0.0068
563 TRANSAMINASES INCREASED 151 0.0068
564 RENAL CELL CARCINOMA 33 0.0067
565 ALANINE AMINOTRANSFERASE INCREASED 413 0.0067
566 GASTROINTESTINAL CARCINOMA 61 0.0067
567 INFLUENZA LIKE ILLNESS 551 0.0067
568 FEELING HOT 410 0.0067
569 NEOPLASM MALIGNANT 446 0.0067
570 SPINAL PAIN 78 0.0067
571 ILEUS 82 0.0066
572 TENDON DISORDER 43 0.0066
573 AUTOIMMUNE HEPATITIS 45 0.0065
574 PRODUCT PRESCRIBING ERROR 154 0.0065
575 CHOLECYSTITIS 77 0.0065
576 POST PROCEDURAL COMPLICATION 124 0.0065
577 TENDERNESS 67 0.0064
578 URINARY TRACT INFECTION 1095 0.0064
579 LARGE INTESTINE POLYP 44 0.0063
580 ANKLE FRACTURE 98 0.0063
581 ANAPHYLACTIC REACTION 349 0.0063
582 SKIN EXFOLIATION 531 0.0063
583 VIRAL INFECTION 209 0.0063
584 SKIN LACERATION 68 0.0062
585 FOETAL EXPOSURE DURING PREGNANCY 508 0.0062
586 RHINORRHOEA 401 0.0062
587 OVARIAN CYST 62 0.0062
588 CORONAVIRUS INFECTION 41 0.0062
589 ASPARTATE AMINOTRANSFERASE INCREASED 329 0.0062
590 CHOLECYSTITIS ACUTE 35 0.0062
591 ABORTION SPONTANEOUS 247 0.0062
592 GENERALISED ERYTHEMA 35 0.0061
593 ASTHENIA 2292 0.0061
594 CONCUSSION 47 0.0061
595 COVID-19 1064 0.0061
596 INCONTINENCE 64 0.0060
597 LARGE INTESTINE PERFORATION 42 0.0060
598 HEPATITIS C 73 0.0060
599 SKIN WARM 35 0.0060
600 TREATMENT NONCOMPLIANCE 328 0.0060
601 HYPERKERATOSIS 33 0.0060
602 ADRENAL INSUFFICIENCY 72 0.0059
603 FLUID RETENTION 300 0.0059
604 GENERAL PHYSICAL CONDITION ABNORMAL 40 0.0059
605 QUALITY OF LIFE DECREASED 79 0.0059
606 DYSARTHRIA 221 0.0059
607 UROSEPSIS 54 0.0058
608 MUSCULOSKELETAL DISORDER 111 0.0058
609 ANXIETY 1648 0.0058
610 PRODUCT COMPLAINT 146 0.0058
611 UTERINE CANCER 46 0.0057
612 NAUSEA 4528 0.0057
613 LUNG NEOPLASM MALIGNANT 235 0.0057
614 SEPSIS 635 0.0057
615 VASCULITIS 66 0.0057
616 BRAIN NEOPLASM 52 0.0057
617 DIZZINESS 2809 0.0056
618 DERMATITIS 118 0.0056
619 DYSPNOEA 3162 0.0056
620 SKIN REACTION 78 0.0055
621 HAEMORRHOIDS 108 0.0055
622 TRANSIENT ISCHAEMIC ATTACK 186 0.0055
623 PRODUCT DISTRIBUTION ISSUE 51 0.0055
624 SCAB 62 0.0054
625 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 298 0.0054
626 PAPULE 38 0.0054
627 DUODENAL ULCER 38 0.0054
628 PRODUCT ADMINISTRATION ERROR 108 0.0053
629 NERVE COMPRESSION 49 0.0053
630 NERVE INJURY 59 0.0053
631 APPETITE DISORDER 35 0.0053
632 CEREBROVASCULAR ACCIDENT 890 0.0052
633 COVID-19 PNEUMONIA 62 0.0052
634 BACTERAEMIA 62 0.0052
635 PROCEDURAL COMPLICATION 40 0.0052
636 THERAPY PARTIAL RESPONDER 81 0.0052
637 GOUT 93 0.0052
638 GASTROINTESTINAL PAIN 57 0.0052
639 TACHYCARDIA 459 0.0052
640 CHEST DISCOMFORT 529 0.0052
641 SPINAL OPERATION 63 0.0051
642 PRODUCT QUALITY ISSUE 694 0.0051
643 DEVICE LEAKAGE 221 0.0051
644 ANGINA UNSTABLE 33 0.0051
645 JOINT EFFUSION 35 0.0051
646 CARDIAC OPERATION 43 0.0050
647 OROPHARYNGEAL PAIN 457 0.0049
648 MOUTH ULCERATION 104 0.0049
649 CYTOMEGALOVIRUS INFECTION 82 0.0049
650 EPISTAXIS 368 0.0049
651 PRODUCT DISPENSING ERROR 107 0.0049
652 PRODUCT CONTAINER ISSUE 42 0.0049
653 CAESAREAN SECTION 57 0.0049
654 COMPLICATION ASSOCIATED WITH DEVICE 71 0.0049
655 BACTERIAL INFECTION 91 0.0049
656 GAMMA-GLUTAMYLTRANSFERASE INCREASED 108 0.0049
657 PAIN OF SKIN 130 0.0048
658 GALLBLADDER DISORDER 86 0.0048
659 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
660 SPLENOMEGALY 56 0.0048
661 BREAST CANCER 444 0.0048
662 PANCREATITIS ACUTE 107 0.0048
663 SKIN FISSURES 93 0.0048
664 HYPERAESTHESIA 39 0.0047
665 ABNORMAL LOSS OF WEIGHT 32 0.0047
666 ABDOMINAL PAIN LOWER 116 0.0046
667 SLEEP APNOEA SYNDROME 86 0.0045
668 PNEUMONIA BACTERIAL 41 0.0045
669 LEUKAEMIA 42 0.0044
670 NODULE 58 0.0044
671 BLOOD ALBUMIN DECREASED 35 0.0044
672 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 230 0.0044
673 PHARYNGEAL SWELLING 43 0.0044
674 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
675 UTERINE LEIOMYOMA 32 0.0044
676 BLOOD DISORDER 35 0.0044
677 THERAPEUTIC RESPONSE SHORTENED 144 0.0043
678 AORTIC ANEURYSM 33 0.0043
679 NEUTROPHIL COUNT INCREASED 44 0.0043
680 THROAT TIGHTNESS 116 0.0043
681 HYPOALBUMINAEMIA 33 0.0042
682 BODY TEMPERATURE INCREASED 86 0.0042
683 MYASTHENIA GRAVIS 34 0.0042
684 DIABETES MELLITUS 319 0.0042
685 TOOTH EXTRACTION 52 0.0042
686 ERYTHEMA 846 0.0041
687 FOOT FRACTURE 78 0.0041
688 FALL 1355 0.0041
689 LIMB INJURY 107 0.0039
690 SPINAL DISORDER 37 0.0039
691 THERAPY INTERRUPTED 279 0.0039
692 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
693 ACNE 293 0.0039
694 ACUTE CORONARY SYNDROME 32 0.0039
695 BACK PAIN 897 0.0039
696 HYPOKINESIA 55 0.0038
697 LEUKOPENIA 189 0.0038
698 HEPATOMEGALY 37 0.0038
699 PHOTOSENSITIVITY REACTION 62 0.0038
700 WRIST FRACTURE 45 0.0038
701 OPTIC NEURITIS 34 0.0037
702 PHOTOPHOBIA 70 0.0037
703 CONJUNCTIVITIS 69 0.0037
704 OVARIAN CANCER 34 0.0037
705 GASTRITIS 97 0.0037
706 HEPATOTOXICITY 82 0.0037
707 ILLNESS 373 0.0036
708 BLOOD CREATININE INCREASED 236 0.0036
709 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
710 DEVICE OCCLUSION 50 0.0035
711 DEMENTIA 99 0.0035
712 LYMPHOPENIA 50 0.0035
713 PROSTATE CANCER 283 0.0035
714 SCAR 60 0.0035
715 ISCHAEMIC STROKE 62 0.0035
716 ASPIRATION 38 0.0035
717 INCORRECT DOSE ADMINISTERED 792 0.0035
718 BLOOD PRESSURE INCREASED 528 0.0035
719 BREAST CANCER STAGE I 32 0.0034
720 BLOOD TRIGLYCERIDES INCREASED 61 0.0034
721 ACCIDENT 41 0.0034
722 BLADDER DISORDER 34 0.0034
723 MYALGIA 581 0.0034
724 PROSTATIC SPECIFIC ANTIGEN INCREASED 47 0.0034
725 HALLUCINATION, AUDITORY 54 0.0034
726 SYNCOPE 339 0.0034
727 MUSCULOSKELETAL CHEST PAIN 52 0.0034
728 BODY TEMPERATURE DECREASED 33 0.0033
729 LIGAMENT SPRAIN 33 0.0033
730 NEURALGIA 81 0.0033
731 TENDON RUPTURE 41 0.0033
732 UNEVALUABLE EVENT 251 0.0033
733 COUGH 930 0.0033
734 MYOCARDIAL INFARCTION 577 0.0033
735 PALPITATIONS 387 0.0033
736 ECZEMA 172 0.0033
737 GASTRIC ULCER 62 0.0033
738 PREMATURE BABY 98 0.0033
739 PARANOIA 56 0.0032
740 DYSPHAGIA 308 0.0032
741 HYPERSOMNIA 93 0.0032
742 PERITONITIS 67 0.0032
743 INTERSTITIAL LUNG DISEASE 155 0.0032
744 BEDRIDDEN 42 0.0032
745 CARDIOMYOPATHY 47 0.0032
746 HYPERTHYROIDISM 46 0.0032
747 DENTAL CARIES 35 0.0032
748 PNEUMOTHORAX 50 0.0031
749 SWELLING FACE 205 0.0031
750 NASAL CONGESTION 185 0.0031
751 SUBARACHNOID HAEMORRHAGE 32 0.0031
752 SEPTIC SHOCK 136 0.0031
753 VERTIGO 190 0.0031
754 MULTIPLE SCLEROSIS 149 0.0031
755 DRUG EFFECT LESS THAN EXPECTED 46 0.0031
756 HAEMORRHAGE 323 0.0031
757 SCRATCH 32 0.0030
758 ACUTE MYOCARDIAL INFARCTION 89 0.0030
759 NERVOUS SYSTEM DISORDER 94 0.0030
760 POLYNEUROPATHY 36 0.0030
761 INJURY ASSOCIATED WITH DEVICE 61 0.0030
762 BURNING SENSATION 210 0.0030
763 RIB FRACTURE 61 0.0030
764 UPPER LIMB FRACTURE 59 0.0030
765 BLOOD URINE PRESENT 56 0.0029
766 DEEP VEIN THROMBOSIS 189 0.0029
767 ACUTE MYELOID LEUKAEMIA 45 0.0029
768 MYOCARDITIS 33 0.0029
769 SEIZURE 332 0.0029
770 PRODUCT USE COMPLAINT 45 0.0029
771 MENTAL DISORDER 124 0.0028
772 LOSS OF CONSCIOUSNESS 364 0.0028
773 DISEASE RECURRENCE 135 0.0028
774 PLATELET COUNT INCREASED 37 0.0028
775 PULMONARY EMBOLISM 269 0.0028
776 RASH ERYTHEMATOUS 135 0.0028
777 DERMATITIS ALLERGIC 35 0.0028
778 BLOOD TEST ABNORMAL 39 0.0028
779 IMPAIRED WORK ABILITY 59 0.0028
780 DEAFNESS 72 0.0028
781 THROMBOSIS 221 0.0027
782 HEPATIC CANCER 66 0.0027
783 PARAESTHESIA ORAL 39 0.0027
784 HIATUS HERNIA 35 0.0027
785 OSTEOPENIA 41 0.0027
786 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 546 0.0027
787 BRAIN OEDEMA 34 0.0027
788 ANAPHYLACTIC SHOCK 69 0.0027
789 FLATULENCE 151 0.0027
790 SKIN DISCOLOURATION 122 0.0027
791 PULMONARY CONGESTION 35 0.0027
792 HEAD INJURY 84 0.0027
793 TOOTH DISORDER 59 0.0027
794 ROTATOR CUFF SYNDROME 34 0.0026
795 SWOLLEN TONGUE 82 0.0026
796 DRUG RESISTANCE 67 0.0026
797 INJECTION SITE HAEMORRHAGE 208 0.0026
798 POOR QUALITY SLEEP 56 0.0026
799 PANCREATIC CARCINOMA 75 0.0026
800 SPINAL FRACTURE 52 0.0026
801 PRURITUS GENERALISED 56 0.0026
802 THERAPEUTIC RESPONSE UNEXPECTED 116 0.0026
803 CEREBRAL INFARCTION 63 0.0026
804 PRODUCT PHYSICAL ISSUE 52 0.0026
805 RENAL DISORDER 120 0.0026
806 MUSCULOSKELETAL DISCOMFORT 44 0.0026
807 SENSORY DISTURBANCE 41 0.0026
808 DEHYDRATION 337 0.0025
809 INTRAOCULAR PRESSURE INCREASED 32 0.0025
810 DEVICE USE ERROR 87 0.0025
811 LETHARGY 144 0.0025
812 EYE SWELLING 93 0.0025
813 ANAEMIA 475 0.0025
814 RASH MACULAR 87 0.0025
815 HIP FRACTURE 80 0.0025
816 INCORRECT DOSE ADMINISTERED BY DEVICE 65 0.0025
817 INJECTION SITE RASH 76 0.0025
818 INCORRECT ROUTE OF DRUG ADMINISTRATION 88 0.0025
819 FLUSHING 250 0.0025
820 EOSINOPHILIA 43 0.0025
821 RENAL IMPAIRMENT 206 0.0024
822 PRODUCTIVE COUGH 116 0.0024
823 THROAT IRRITATION 109 0.0024
824 LIMB DISCOMFORT 75 0.0024
825 MYELODYSPLASTIC SYNDROME 35 0.0024
826 ASCITES 71 0.0024
827 VISION BLURRED 330 0.0024
828 DEPRESSED MOOD 127 0.0024
829 RASH GENERALISED 62 0.0024
830 ACUTE RESPIRATORY FAILURE 46 0.0024
831 PNEUMONITIS 65 0.0024
832 COLD SWEAT 42 0.0024
833 DRY SKIN 318 0.0024
834 INJECTION SITE SWELLING 182 0.0024
835 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
836 DIABETES MELLITUS INADEQUATE CONTROL 42 0.0024
837 ATRIAL FIBRILLATION 231 0.0024
838 PSYCHOTIC DISORDER 70 0.0024
839 THROMBOCYTOPENIA 256 0.0023
840 HAEMATURIA 78 0.0023
841 PANIC ATTACK 83 0.0023
842 GASTRIC CANCER 57 0.0022
843 BLINDNESS 91 0.0022
844 PRESYNCOPE 54 0.0022
845 MUCOSAL INFLAMMATION 58 0.0022
846 HYPERHIDROSIS 285 0.0022
847 PROCEDURAL PAIN 61 0.0022
848 MIDDLE INSOMNIA 41 0.0022
849 BLOOD POTASSIUM DECREASED 66 0.0022
850 CARDIAC FAILURE 176 0.0022
851 HOT FLUSH 163 0.0022
852 EYE DISORDER 71 0.0022
853 DYSSTASIA 63 0.0022
854 ANGIOEDEMA 95 0.0021
855 TUBULOINTERSTITIAL NEPHRITIS 40 0.0021
856 FAECES DISCOLOURED 46 0.0021
857 MOVEMENT DISORDER 68 0.0021
858 TOOTHACHE 38 0.0021
859 RASH PAPULAR 47 0.0021
860 CHILLS 244 0.0021
861 FRACTURE 39 0.0021
862 HAEMOGLOBIN DECREASED 210 0.0020
863 LEUKOCYTOSIS 37 0.0020
864 HYPOTHYROIDISM 65 0.0020
865 HEAD DISCOMFORT 36 0.0020
866 BONE DISORDER 37 0.0020
867 CONSTIPATION 442 0.0020
868 DYSPHONIA 118 0.0020
869 CARDIOVASCULAR DISORDER 51 0.0020
870 FEELING ABNORMAL 477 0.0020
871 HEART RATE INCREASED 196 0.0020
872 INJECTION SITE PAIN 606 0.0020
873 THIRST 35 0.0020
874 NEUROPATHY PERIPHERAL 186 0.0020
875 PLASMA CELL MYELOMA 76 0.0019
876 INTENTIONAL PRODUCT MISUSE 169 0.0019
877 DRUG PRESCRIBING ERROR 37 0.0019
878 INJECTION SITE BRUISING 153 0.0019
879 BLOOD PRESSURE FLUCTUATION 46 0.0019
880 MUSCLE TWITCHING 44 0.0019
881 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
882 ERECTILE DYSFUNCTION 48 0.0019
883 BLOOD PRESSURE ABNORMAL 37 0.0019
884 OSTEONECROSIS 61 0.0019
885 DIPLOPIA 48 0.0018
886 DEVICE USE ISSUE 32 0.0018
887 HEPATIC FAILURE 55 0.0018
888 HEART RATE IRREGULAR 41 0.0018
889 EXPOSURE VIA SKIN CONTACT 47 0.0018
890 PALLOR 49 0.0018
891 INJECTION SITE ERYTHEMA 223 0.0018
892 DRY EYE 89 0.0018
893 HYPOKALAEMIA 82 0.0018
894 CEREBRAL HAEMORRHAGE 63 0.0018
895 PRODUCT PRESCRIBING ISSUE 38 0.0017
896 DRUG DOSE OMISSION BY DEVICE 136 0.0017
897 RENAL CANCER 82 0.0017
898 LACRIMATION INCREASED 52 0.0017
899 EXPIRED PRODUCT ADMINISTERED 57 0.0017
900 PRODUCT AVAILABILITY ISSUE 39 0.0017
901 SUICIDAL IDEATION 156 0.0017
902 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
903 BLADDER CANCER 100 0.0017
904 CARDIAC DISORDER 158 0.0017
905 PERICARDIAL EFFUSION 39 0.0017
906 SKIN BURNING SENSATION 120 0.0017
907 PLEURAL EFFUSION 101 0.0017
908 BONE PAIN 96 0.0016
909 MELAENA 36 0.0016
910 INJECTION SITE PRURITUS 109 0.0016
911 ARRHYTHMIA 77 0.0016
912 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
913 LIP SWELLING 54 0.0016
914 HAEMATOMA 42 0.0016
915 CARDIAC FAILURE CONGESTIVE 130 0.0016
916 SKIN IRRITATION 71 0.0015
917 MOOD SWINGS 49 0.0015
918 HYPOACUSIS 65 0.0015
919 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
920 DYSURIA 55 0.0015
921 EYE PAIN 84 0.0015
922 JAUNDICE 40 0.0015
923 RESPIRATORY DISTRESS 41 0.0015
924 DEATH 1273 0.0015
925 OVERDOSE 318 0.0015
926 INJECTION SITE MASS 54 0.0015
927 NERVOUSNESS 76 0.0015
928 GASTROINTESTINAL HAEMORRHAGE 121 0.0014
929 MENTAL IMPAIRMENT 35 0.0014
930 PNEUMONIA ASPIRATION 36 0.0014
931 RESPIRATORY FAILURE 105 0.0014
932 TINNITUS 66 0.0014
933 RED BLOOD CELL COUNT DECREASED 41 0.0014
934 POLLAKIURIA 59 0.0014
935 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41 0.0014
936 SPEECH DISORDER 73 0.0014
937 RENAL FAILURE 185 0.0014
938 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 64 0.0014
939 FEELING COLD 37 0.0013
940 FEMUR FRACTURE 41 0.0013
941 PULMONARY OEDEMA 59 0.0013
942 HEART RATE DECREASED 46 0.0013
943 HYPOTENSION 262 0.0013
944 ENCEPHALOPATHY 32 0.0013
945 BLOOD BILIRUBIN INCREASED 35 0.0013
946 URINARY RETENTION 43 0.0013
947 TREMOR 213 0.0013
948 EYE PRURITUS 43 0.0013
949 OCULAR HYPERAEMIA 60 0.0013
950 CORONARY ARTERY DISEASE 38 0.0013
951 WHITE BLOOD CELL COUNT DECREASED 136 0.0013
952 HYPOPHAGIA 32 0.0013
953 DISORIENTATION 49 0.0012
954 BLOOD PRESSURE DECREASED 82 0.0012
955 DYSPNOEA EXERTIONAL 45 0.0012
956 ACUTE KIDNEY INJURY 182 0.0012
957 BALANCE DISORDER 102 0.0012
958 EMOTIONAL DISTRESS 129 0.0011
959 DISEASE PROGRESSION 125 0.0011
960 PRODUCT SUBSTITUTION ISSUE 57 0.0010
961 COMA 47 0.0010
962 SOMNOLENCE 198 0.0010
963 DYSGEUSIA 72 0.0010
964 CHRONIC KIDNEY DISEASE 73 0.0010
965 BLOOD GLUCOSE INCREASED 180 0.0010
966 DEVICE BREAKAGE 37 0.0009
967 CARDIAC ARREST 75 0.0009
968 DISTURBANCE IN ATTENTION 48 0.0009
969 CARDIO-RESPIRATORY ARREST 36 0.0009
970 PLATELET COUNT DECREASED 89 0.0008
971 DERMATITIS ATOPIC 43 0.0008
972 HYPOGLYCAEMIA 38 0.0008
973 SUICIDE ATTEMPT 47 0.0008
974 EYE IRRITATION 44 0.0008
975 WITHDRAWAL SYNDROME 32 0.0008
976 PANCYTOPENIA 42 0.0008
977 OXYGEN SATURATION DECREASED 41 0.0007
978 COGNITIVE DISORDER 33 0.0007
979 BLOOD GLUCOSE DECREASED 33 0.0007
980 DRUG INTERACTION 106 0.0007
981 NEUTROPENIA 87 0.0006
982 IRRITABILITY 38 0.0006
983 HALLUCINATION 46 0.0006
984 NO ADVERSE EVENT 97 0.0005
985 AGITATION 39 0.0005
986 DEVICE DIFFICULT TO USE 33 0.0005
987 TOXICITY TO VARIOUS AGENTS 46 0.0003